
Seelos Therapeutics, Inc.
USD0.37
CEO
Raj Mehra
IPO Date
1999-04-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Day Low
$0.37
Day High
$0.37
52W Low
$0.37
52W High
$0.37
Market Cap
$0.00B
Seelos Therapeutics Announces Positive In Vivo Data Demonstrating Down-Regulation of SNCA mRNA and Protein Expression from a Gene Therapy Study of SLS-004 Utilizing CRISPR-dCas9 for Parkinson's Disease Pathology